Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the ...

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company’s AI-enabled Drug Development Strategy PHILADELPHIA, PA / ACCESS Newswire / March 10, 2026 / ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Stage and screen actor Robert Lindsay, 76, is the 100,000th signature to the petition calling for prostate cancer screening ...

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...

A global phase 3 trial enrolled mHSPC with ≥90% PTEN loss by IHC and randomized 1,012 patients to intermittent capivasertib plus abiraterone/prednisone versus ...

Radiopharmaceuticals therapy (RPT) has been a major breakthrough in the treatment of prostate cancer. This therapy utilizes radioactive isotopes targeted specifically to prostate cancer, combining the ...

3-in-1 therapies (compression, vibration, and LED) to optimize recovery. Features preset routines and customizable settings. Fully wireless. Available in three sizes. Limited transparency around the ...

Prostatic stromal sarcoma (PSS) is a rare malignant mesenchymal tumor originating from the specialized stroma of the prostate. It is a heterogeneous tumor, in which a predominantly phyllodes ...

In patients undergoing RP with adjuvant radiation, PLND showed no survival benefit, regardless of prostate cancer risk group or number of lymph nodes removed. Pelvic lymph node dissection (PLND) ...

uDepartment of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA vGlobal Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA wDepartment of Translational Medicine, Bristol ...

GDF15 functions as a dual-edged regulator within the TME. On one hand, it suppresses anti-tumor immunity by impairing T cell recruitment and adhesion through inhibition of LFA-1/β2-integrin–mediated ...